Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Fulcrum Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 102 | 105 | +3 |
| Shares | 40.0M | 52.2M | +12.2M (+30.4%) |
| Value | $196.6M | $422.1M | +$225.5M (+114.7%) |
New holders (24)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (21)
Institutions that held Fulcrum Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Investments, LP | 214,763 | $1.05M |
| Millennium Management LLC | 81,197 | $398.0K |
| Renaissance Technologies LLC | 68,000 | $333.0K |
| Tekla Capital Management LLC | 58,537 | $287.0K |
| Jane Street Group, LLC | 37,930 | $186.0K |
| Qube Research & Technologies Ltd | 31,813 | $156.0K |
| Squarepoint Ops LLC | 30,936 | $152.0K |
| Victory Capital Management Inc | 30,012 | $147.0K |
| Jump Financial, LLC | 29,000 | $142.0K |
| XTX Topco Ltd | 27,799 | $136.0K |
| Cornercap Investment Counsel Inc | 25,941 | $127.0K |
| Engineers Gate Manager LP | 21,356 | $105.0K |
| Balyasny Asset Management LLC | 15,684 | $77.0K |
| AQR Capital Management LLC | 13,966 | $68.0K |
| Simplex Trading, LLC | 14,005 | $68.0K |
| Delphia (USA) Inc. | 11,784 | $58.0K |
| Corton Capital Inc. | 10,759 | $53.0K |
| STRS Ohio | 6,800 | $33.0K |
| Point72 Hong Kong Ltd | 4,495 | $22.0K |
| Denali Advisors LLC | 3,900 | $19.0K |
| Captrust Financial Advisors | 72 | $0 |